There has been an increase in adult stem cell therapy clinical trials which are showing great promise in the areas of skin and wound healing, orthopedics, and in treating diseases including peripheral vascular disease, scleroderma, diabetes, congestive heart failure, myocardial infarction, and much more. Industry sources estimates that the global stem cell product market is expected to reach $88 billion by 2014.

For more information on clinical trials using adult stem cells, please visit the United States National Institutes of Health Clinical Trials database at where you can search for clinical trials by disease or by cell type to see clinical trial examples.

Comments are closed.